يعرض 281 - 300 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significance ((nn decrease) OR (step decrease)) ))*', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 281

    Flow chart of study participants. حسب Eva Rydahl (6260771)

    منشور في 2025
    الموضوعات:
  2. 282
  3. 283

    Absolute numbers among CS groups. حسب Eva Rydahl (6260771)

    منشور في 2025
    الموضوعات:
  4. 284
  5. 285
  6. 286

    Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. حسب Luqiong Liu (11537092)

    منشور في 2024
    "…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …"
  7. 287
  8. 288
  9. 289

    Patient Example. حسب James M. Friedman (22522150)

    منشور في 2025
    الموضوعات:
  10. 290
  11. 291
  12. 292

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  13. 293
  14. 294
  15. 295

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  16. 296

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  17. 297
  18. 298
  19. 299
  20. 300